Bal Pharma Limited
NSE:BALPHARMA.NS
123.23 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 132.923 | 14.872 | 11.128 | 10.234 | 8.587 | 24.361 | 27.086 | 46.356 | 46.344 | 54.944 | 30.242 | 47.284 | 30.267 | 22.303 | 16.148 | 13.609 | 29.014 |
| Short Term Investments
| 67.567 | 75.939 | 49.717 | 29.475 | 26.479 | 17.097 | 13.31 | 24.609 | -3.194 | -2.933 | -0.022 | -0.574 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 200.49 | 90.811 | 60.845 | 39.709 | 35.066 | 41.458 | 40.396 | 46.356 | 46.344 | 54.944 | 30.242 | 47.284 | 30.267 | 22.303 | 16.148 | 13.609 | 29.014 |
| Net Receivables
| 1,009.897 | 950.813 | 1,036.476 | 994.775 | 899.816 | 954.396 | 1,054.076 | 1,018.958 | 965.43 | 636.155 | 602.501 | 545.462 | 474.992 | 0 | 0 | 0 | 0 |
| Inventory
| 878.114 | 980.05 | 743.956 | 603.853 | 677.113 | 697.511 | 664.934 | 547.307 | 417.542 | 358.152 | 317.142 | 336.87 | 336.595 | 322.144 | 286.224 | 238.861 | 254.5 |
| Other Current Assets
| 261.601 | 259.885 | 4.429 | 3.136 | -0.699 | 125.701 | -0.004 | 1.68 | 0.664 | 1.994 | 1.28 | 2.523 | 3.116 | 464.558 | 389.667 | 360.067 | 299.136 |
| Total Current Assets
| 2,350.102 | 2,281.559 | 1,845.706 | 1,641.473 | 1,611.296 | 1,819.066 | 1,759.402 | 1,614.301 | 1,429.979 | 1,051.245 | 951.165 | 932.139 | 844.97 | 809.005 | 692.04 | 612.537 | 582.65 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 620.773 | 621.792 | 572.751 | 575.087 | 637.695 | 644.778 | 634.131 | 571.422 | 555.282 | 480.92 | 505.59 | 476.16 | 476.655 | 484.443 | 497.508 | 553.273 | 459.282 |
| Goodwill
| 38.286 | 38.286 | 38.286 | 38.286 | 38.286 | 38.286 | 29.026 | 0 | 0 | 48.246 | 48.656 | 50.861 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 113.814 | 104.57 | 83.016 | 72.482 | 64.282 | 57.119 | 44.738 | 46.693 | 46.288 | 0.486 | 0.001 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 152.1 | 142.856 | 121.302 | 110.768 | 102.568 | 95.405 | 73.764 | 46.693 | 46.288 | 48.731 | 48.657 | 50.871 | 56.444 | 59.439 | 52.321 | 49.399 | 46.322 |
| Long Term Investments
| 27.82 | -40.898 | -43.93 | -21.413 | 10.192 | 7.883 | -8.019 | 3.424 | 3.344 | 3.083 | 0.172 | 0.724 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 24.121 | 21.666 | 18.736 | 51.611 | 22.119 | -7.883 | 59.113 | 11.709 | 10.099 | -3.083 | -0.172 | -0.724 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 28.974 | 104.745 | 90.764 | 43.278 | 0.001 | 53.834 | -0.246 | 54.673 | 65.311 | 57.733 | 42.029 | 39.206 | 33.568 | 0.15 | 0.15 | 0.15 | 0.15 |
| Total Non-Current Assets
| 853.788 | 850.161 | 759.623 | 759.331 | 772.575 | 794.017 | 758.743 | 687.921 | 680.324 | 587.384 | 596.275 | 566.237 | 566.667 | 544.032 | 549.978 | 602.822 | 505.755 |
| Total Assets
| 3,203.89 | 3,131.723 | 2,605.327 | 2,400.804 | 2,383.871 | 2,613.083 | 2,518.145 | 2,302.223 | 2,110.303 | 1,638.628 | 1,547.441 | 1,498.376 | 1,411.638 | 1,353.037 | 1,242.018 | 1,215.36 | 1,088.405 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 783.278 | 789.229 | 655.639 | 471.665 | 386.74 | 473.379 | 452.616 | 513.613 | 468.511 | 385.349 | 335.309 | 320.564 | 269.217 | 5.877 | 4.725 | 17.434 | 13.737 |
| Short Term Debt
| 1,032.66 | 1,004.761 | 773.882 | 863.988 | 961.52 | 947.452 | 749.364 | 562.872 | 500.915 | 401.379 | 427.499 | 443.597 | 445.294 | 8.851 | 1.621 | 0 | 0 |
| Tax Payables
| 22.176 | 23.921 | 43.926 | 6.139 | 5.826 | 4.589 | 19.96 | 11.002 | 3.852 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 22.176 | 122.296 | 192.038 | 112.32 | 193.778 | 119.357 | 129.696 | 82.977 | 22.398 | 18.282 | 18.314 | 12.807 | 9.108 | 316.363 | 251.324 | 0 | 0 |
| Other Current Liabilities
| 200.945 | 177.058 | 34.889 | 77.356 | 52.877 | 92.189 | 120.375 | 55.465 | 120.097 | 118.574 | 86.593 | 149.693 | 139.566 | 14.789 | 20.17 | 296.022 | 222.901 |
| Total Current Liabilities
| 2,039.059 | 2,093.344 | 1,656.448 | 1,525.329 | 1,594.915 | 1,632.377 | 1,452.051 | 1,214.927 | 1,111.922 | 923.584 | 867.715 | 926.661 | 863.185 | 345.88 | 277.841 | 313.456 | 236.639 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 363.824 | 305.231 | 292.671 | 255.473 | 242.671 | 287.56 | 350.271 | 368.227 | 349.566 | 66.443 | 79.701 | 16.71 | 60.909 | 577.303 | 544.188 | 471.683 | 451.499 |
| Deferred Revenue Non-Current
| -0 | 4.511 | 18.302 | 19.491 | 20.938 | 22.009 | 12.709 | 28.368 | 22.846 | 16.518 | 10.598 | 8.35 | 6.437 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 39.61 | 28.691 | 6.044 | 26.321 | 35.839 | 41.798 | 75.676 | 77.536 | 69.784 | 72.948 | 82.372 | 82.372 | 74.177 | 68.102 | 62.368 | 57.874 | 49.944 |
| Other Non-Current Liabilities
| 68.783 | 62.924 | 46.938 | 40.654 | 36.131 | 27.127 | 25.423 | 12.859 | 8.959 | 7.459 | 6.559 | 18.1 | 6.372 | 0 | 0 | 0 | -0 |
| Total Non-Current Liabilities
| 472.217 | 401.357 | 363.955 | 341.939 | 335.579 | 378.494 | 464.079 | 486.99 | 451.156 | 163.369 | 179.23 | 125.531 | 147.895 | 645.405 | 606.555 | 529.558 | 501.443 |
| Total Liabilities
| 2,511.276 | 2,494.701 | 2,020.403 | 1,867.268 | 1,930.494 | 2,010.871 | 1,916.13 | 1,701.917 | 1,563.078 | 1,086.953 | 1,046.945 | 1,052.192 | 1,011.079 | 991.285 | 884.397 | 843.014 | 738.082 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 158.044 | 156.899 | 148.224 | 148.224 | 141.724 | 141.724 | 141.724 | 141.724 | 128.724 | 128.724 | 111.114 | 105.736 | 105.736 | 104.832 | 104.832 | 104.832 | 104.462 |
| Retained Earnings
| 193.419 | 146.885 | 135.813 | 94.519 | 125.863 | 265.129 | 244.337 | 218.442 | 198.059 | 201.063 | 189.302 | 176.093 | 0 | 80.452 | 76.373 | 90.662 | 69.932 |
| Accumulated Other Comprehensive Income/Loss
| 534.899 | 32.267 | 35.463 | 26.305 | 15.908 | 18.811 | 23.057 | 25.457 | 49.071 | 24.556 | 21.77 | 16.474 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| -193.419 | 301.84 | 266.768 | 266.766 | 240.766 | 240.766 | 240.765 | 244.23 | 173.166 | 197.681 | 178.31 | 147.88 | 294.822 | 176.468 | 176.416 | 176.852 | 175.929 |
| Total Shareholders Equity
| 692.943 | 637.891 | 586.268 | 535.814 | 524.261 | 666.43 | 649.883 | 629.853 | 549.02 | 552.024 | 500.496 | 446.184 | 400.558 | 361.752 | 357.621 | 372.346 | 350.323 |
| Total Equity
| 692.614 | 637.022 | 584.924 | 533.536 | 453.377 | 602.212 | 602.015 | 600.306 | 547.225 | 551.675 | 500.496 | 446.184 | 400.558 | 361.752 | 357.621 | 372.346 | 350.323 |
| Total Liabilities & Shareholders Equity
| 3,203.89 | 3,131.723 | 2,605.327 | 2,400.804 | 2,383.871 | 2,613.083 | 2,518.145 | 2,302.223 | 2,110.303 | 1,638.628 | 1,547.441 | 1,498.376 | 1,411.638 | 1,353.037 | 1,242.018 | 1,215.36 | 1,088.405 |